Professional
Added to YB: 2025-05-30
Pitch date: 2025-05-27
BRKR [neutral]
Bruker Corporation
+65.93%
current return
Author Info
No bio for this author
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Market Cap
$8.3B
Pitch Price
$36.97
Price Target
N/A
Dividend
0.37%
EV/EBITDA
18.34
P/E
-226.89
EV/Sales
2.86
Sector
Life Sciences Tools and Services
Category
value
RGA Investment Advisors Portfolio Holding: Bruker Corporation
BRKR (holding update): Life science instrumentation leader in mass spec/NMR duopoly with TMO. Trading at mid-teens P/E despite diversification since 2012 sequestration. CEO (30% owner) targeting margins to expand from 15% to mid-20s. Near-term macro challenges but growth drivers intact. Expect multiple expansion from current ~5x forward P/E.
Read full article (2 min)